BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 21428970)

  • 1. Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo.
    Kumar R; Parsad D; Kanwar AJ; Kaul D
    Br J Dermatol; 2011 Aug; 165(2):285-91. PubMed ID: 21428970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant ETS-1 signalling impedes the expression of cell adhesion molecules and matrix metalloproteinases in non-segmental vitiligo.
    Srivastava N; Bishnoi A; Mehta S; Rani S; Kumar R; Bhardwaj S; Sendhil Kumaran M; Keshavamurthy V; Gupta S; Parsad D
    Exp Dermatol; 2020 Jun; 29(6):539-547. PubMed ID: 32350934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro migration of melanoblasts requires matrix metalloproteinase-2: implications to vitiligo therapy by photochemotherapy.
    Lei TC; Vieira WD; Hearing VJ
    Pigment Cell Res; 2002 Dec; 15(6):426-32. PubMed ID: 12453184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo.
    Lan CC; Chen GS; Chiou MH; Wu CS; Chang CH; Yu HS
    Br J Dermatol; 2005 Sep; 153(3):498-505. PubMed ID: 16120133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinase-9 associated with ets-1 proto-oncogene in rat tubulointerstitial cells.
    Naito T; Tanihata Y; Nishimura H; Tanaka T; Higuchi C; Taguchi T; Sanaka T
    Nephrol Dial Transplant; 2005 Nov; 20(11):2333-48. PubMed ID: 16046515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
    Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
    J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine effect on melanocyte proliferation and vitiliginous keratinocyte survival.
    Kim NH; Lee AY
    Exp Dermatol; 2010 Dec; 19(12):1073-9. PubMed ID: 21054556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transforming growth factor-beta1 stimulates matrix metalloproteinase-9 production through ERK activation pathway and upregulation of Ets-1 protein].
    Huang HC; Liu SY; Liang Y; Liu Y; Li JZ; Wang HY
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):328-31. PubMed ID: 15854510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ets-1 is up-regulated together with its target gene products matrix metalloproteinase-2 and matrix metalloproteinase-9 in atypical and anaplastic meningiomas.
    Okuducu AF; Zils U; Michaelis SA; Michaelides S; von Deimling A
    Histopathology; 2006 Jun; 48(7):836-45. PubMed ID: 16722933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M.
    Kitamura R; Tsukamoto K; Harada K; Shimizu A; Shimada S; Kobayashi T; Imokawa G
    J Pathol; 2004 Apr; 202(4):463-75. PubMed ID: 15095274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
    Papakonstantinou E; Dionyssopoulos A; Aletras AJ; Pesintzaki C; Minas A; Karakiulakis G
    J Am Acad Dermatol; 2004 Oct; 51(4):526-33. PubMed ID: 15389186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of matrix metalloproteinase-2, -9 and their inhibitor-1 in hypertrophic scars].
    Xie XF; He LX; Hao XF; Chen B; Jia CY; Sun ZG; Cao YJ; Li DH
    Zhonghua Shao Shang Za Zhi; 2007 Dec; 23(6):444-6. PubMed ID: 18457258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of cartilage matrix metalloproteinases by activated protein C.
    Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
    Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered levels of LXR-α: crucial implications in the pathogenesis of vitiligo.
    Kumar R; Parsad D; Kanwar AJ; Kaul D
    Exp Dermatol; 2012 Nov; 21(11):853-8. PubMed ID: 23163651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
    Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
    Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanocytes are not absent in lesional skin of long duration vitiligo.
    Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
    J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
    Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK506 (tacrolimus) and endothelin combined treatment induces mobility of melanoblasts: new insights into follicular vitiligo repigmentation induced by topical tacrolimus on sun-exposed skin.
    Lan CC; Wu CS; Chen GS; Yu HS
    Br J Dermatol; 2011 Mar; 164(3):490-6. PubMed ID: 21039414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
    Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR
    J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-1 enhances the proliferation of normal human melanocytes in a paradoxical manner from the TNF-α-inhibited condition, but tacrolimus promotes exclusively the cellular migration without proliferation: a proposed action mechanism for combination therapy of phototherapy and topical tacrolimus in vitiligo treatment.
    Lee KY; Jeon SY; Hong JW; Choi KW; Lee CY; Choi SJ; Kim JH; Song KH; Kim KH
    J Eur Acad Dermatol Venereol; 2013 May; 27(5):609-16. PubMed ID: 22404745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.